antiviral immunotherapy

Advertisement

cGxPJobs Banner

HOOKIPA Completes Sale of HBV and HIV Programs to Gilead Sciences

NEW YORK and VIENNA – October 31, 2025 — HOOKIPA Pharma Inc. (OTC: HOOK) announced the completion of the...

By cGxPwire Editor
October 31, 2025

Read More

Advertisement

cGxPJobs

Directory